Wound Care Technologies, Inc. Achieves ISO 13485 Certification

Friday, February 17, 2017 Corporate News
Email Print This Page Comment
An important quality control criterion for international markets.

CHANHASSEN, Minn., Feb. 17, 2017 /PRNewswire/ -- Wound Care Technologies, Inc. is pleased to have received ISO 13485

certification as a medical device manufacturer and distributor. This vital quality management system certification specifies that Wound Care Technologies, the manufacturer of DermaClose® External Tissue Expander, has met the requirements necessary to provide medical devices and related services that consistently meet customer and regulatory requirements.

"We are proud of the hard work that went into attaining this vital certification. It is further proof of our unwavering commitment to our surgeons and their patients throughout the world," said Paul Anderson, CEO of Wound Care Technologies, the manufacturer of DermaClose. "This achievement is also a key step in our goal toward marketing the DermaClose worldwide," he said.

According to the International Organization for Standardization based out of Geneva, Switzerland, "ISO 13485 helps an organization design a quality management system that establishes and maintains the effectiveness of its processes. It reflects a strong commitment to continual improvement and gives customers confidence in the company's ability to bring safe and effective products to market."

The DermaClose® is a controlled force, continuous external tissue expander that facilitates rapid tissue movement to reduce or re-approximate wounds. The DermaClose expands skin around a wound until it has stretched enough to enable the wound edges to be sutured closed. It provides surgeons an alternative to skin grafts while improving clinical outcomes and patient satisfaction. To date, DermaClose has been used in over 17,000 cases in the United States and is backed by 46 published case reports and 20 clinical publications.

Wound Care Technologies, Inc. is a Minnesota based company that developed and markets the DermaClose Continuous External Tissue Expander (http://dermaclose.com/). The DermaClose is a very effective alternative to skin grafts and other treatment modalities such as negative pressure wound therapy. The DermaClose can save significant money by reducing length of hospital stay compared to other treatment methods. The WCT team is proud to be able to assist surgeons in helping their patients achieve better outcomes and get them out of the hospital faster, resulting in overall reduced costs to our healthcare system.

Contact:Paul AndersonWCT, Inc. CEO 952-937-2804146767@email4pr.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/wound-care-technologies-inc-achieves-iso-13485-certification-300409023.html

SOURCE Wound Care Technologies, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook